Other languages Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Real-time Estimate Cboe Europe Other stock markets 05:04:12 2024-05-27 am EDT			5-day change	1st Jan Change
280.2 ^SEK	0.00%		-0.21%	+4.94%

May. 24	Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment	DJ
May. 14	Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member	May. 14
Sobi Finalizes Inaugural SEK3 Billion Bond Issue	May. 08
Sobi Secures Additional EU Indication for Rare Blood Disorder Therapy	May. 08
Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug	Apr. 26
Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A	Apr. 26
Sobi's SEK10 Billion Note Program Gets Regulatory Nod in Sweden	Apr. 26
Avis d'analystes du jour : Hermès, Sanofi, STMicroelectronics, BNP Paribas, Pluxee, Valeo, Nestlé...	Apr. 26
Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
Swedish Orphan Biovitrum AB Provides Earnings Guidance for 2024	Apr. 25
AVIS D'ANALYSTES DU JOUR : Air Liquide, Carrefour, STMicro, Sartorius Stedim Biotech, Schneider, Soitec...	Feb. 22
OPINIONES DE LOS ANALISTAS DEL DÍA : Inditex, Acciona Energia, Merlin Properties, Tod's, Euronext, ...	Feb. 22
Sobi to Expand in South Korea via Rare Disease JV with Handok	Feb. 13
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	Feb. 12
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	Feb. 12
Sobi's Growth Potential Remains 'Tremendous' Amid Conservative FY24 Outlook, RBC Says	Feb. 09
Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024	Feb. 08
Swedish Orphan Biovitrum AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 08
Swedish Orphan Biovitrum AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08
Sobi's Profit to Get Royalty Boost as Sanofi Partnerships Outperform, RBC Says	Feb. 02
Ericsson : nouveau directeur financier début avril	Jan. 23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Other languages

Filters